321 related articles for article (PubMed ID: 28881485)
1. Indices of anti-dengue immunoglobulin G subclasses in adult Mexican patients with febrile and hemorrhagic dengue in the acute phase.
Posadas-Mondragón A; Aguilar-Faisal JL; Chávez-Negrete A; Guillén-Salomón E; Alcántara-Farfán V; Luna-Rojas L; Ávila-Trejo AM; Del Carmen Pacheco-Yépez J
Microbiol Immunol; 2017 Oct; 61(10):433-441. PubMed ID: 28881485
[TBL] [Abstract][Full Text] [Related]
2. Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever.
Shu PY; Chen LK; Chang SF; Yueh YY; Chow L; Chien LJ; Chin C; Lin TH; Huang JH
J Med Virol; 2000 Oct; 62(2):224-32. PubMed ID: 11002252
[TBL] [Abstract][Full Text] [Related]
3. Changes in levels of anti-dengue virus IgG subclasses in patients with disease of varying severity.
Thein S; Aaskov J; Myint TT; Shwe TN; Saw TT; Zaw A
J Med Virol; 1993 Jun; 40(2):102-6. PubMed ID: 8360631
[TBL] [Abstract][Full Text] [Related]
4. Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever.
Bachal R; Alagarasu K; Singh A; Salunke A; Shah P; Cecilia D
Arch Virol; 2015 Oct; 160(10):2435-43. PubMed ID: 26175069
[TBL] [Abstract][Full Text] [Related]
5. Characterization of dengue virus infections in a sample of patients suggests unique clinical, immunological, and virological profiles that impact on the diagnosis of dengue and dengue hemorrhagic fever.
Senaratne T; Wimalaratne H; Alahakoon DG; Gunawardane N; Carr J; Noordeen F
J Med Virol; 2016 Oct; 88(10):1703-10. PubMed ID: 26990973
[TBL] [Abstract][Full Text] [Related]
6. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity.
Lau L; Green AM; Balmaseda A; Harris E
J Clin Virol; 2015 Aug; 69():63-7. PubMed ID: 26209381
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.
Koraka P; Suharti C; Setiati TE; Mairuhu AT; Van Gorp E; Hack CE; Juffrie M; Sutaryo J; Van Der Meer GM; Groen J; Osterhaus AD
J Clin Microbiol; 2001 Dec; 39(12):4332-8. PubMed ID: 11724841
[TBL] [Abstract][Full Text] [Related]
8. Development of antibody biomarkers of long term and recent dengue virus infections.
Nascimento EJM; Huleatt JW; Cordeiro MT; Castanha PMS; George JK; Grebe E; Welte A; Brown M; Burke DS; Marques ETA
J Virol Methods; 2018 Jul; 257():62-68. PubMed ID: 29684416
[TBL] [Abstract][Full Text] [Related]
9. Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar.
Ngwe Tun MM; Thant KZ; Inoue S; Kurosawa Y; Lwin YY; Lin S; Aye KT; Thet Khin P; Myint T; Htwe K; Mapua CA; Natividad FF; Hirayama K; Morita K
J Med Virol; 2013 Jul; 85(7):1258-66. PubMed ID: 23595687
[TBL] [Abstract][Full Text] [Related]
10. Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection.
Ramadhany R; Hirai I; Sasaki T; Ono K; Ramasoota P; Ikuta K; Kurosu T
Antiviral Res; 2015 Dec; 124():61-8. PubMed ID: 26522769
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.
Vivanco-Cid H; Maldonado-Rentería MJ; Sánchez-Vargas LA; Izaguirre-Hernández IY; Hernández-Flores KG; Remes-Ruiz R
Immunol Lett; 2014 Sep; 161(1):89-95. PubMed ID: 24858204
[TBL] [Abstract][Full Text] [Related]
12. Dengue hemorrhagic fever: comparison of patients with primary and secondary infections.
Khurram M; Qayyum W; Hassan SJ; Mumtaz S; Bushra HT; Umar M
J Infect Public Health; 2014; 7(6):489-95. PubMed ID: 24999118
[TBL] [Abstract][Full Text] [Related]
13. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
[TBL] [Abstract][Full Text] [Related]
14. Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.
Chaichana P; Okabayashi T; Puiprom O; Sasayama M; Sasaki T; Yamashita A; Ramasoota P; Kurosu T; Ikuta K
PLoS One; 2014; 9(3):e92173. PubMed ID: 24642752
[TBL] [Abstract][Full Text] [Related]
15. Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, singapore.
Yung CF; Lee KS; Thein TL; Tan LK; Gan VC; Wong JGX; Lye DC; Ng LC; Leo YS
Am J Trop Med Hyg; 2015 May; 92(5):999-1005. PubMed ID: 25825386
[TBL] [Abstract][Full Text] [Related]
16. Methods to discriminate primary from secondary dengue during acute symptomatic infection.
Nguyen THT; Clapham HE; Phung KL; Nguyen TK; DInh TT; Nguyen THQ; Tran VN; Whitehead S; Simmons C; Wolbers M; Wills B
BMC Infect Dis; 2018 Aug; 18(1):375. PubMed ID: 30086716
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the 2013 dengue epidemic in Myanmar with dengue virus 1 as the dominant serotype.
Ngwe Tun MM; Kyaw AK; Makki N; Muthugala R; Nabeshima T; Inoue S; Hayasaka D; Moi ML; Buerano CC; Thwe SM; Thant KZ; Morita K
Infect Genet Evol; 2016 Sep; 43():31-7. PubMed ID: 27154331
[TBL] [Abstract][Full Text] [Related]
18. Studies on dengue and dengue haemorrhagic fever (DHF) in West Bengal State, India.
Hati AK
J Commun Dis; 2006 Mar; 38(2):124-9. PubMed ID: 17370674
[TBL] [Abstract][Full Text] [Related]
19. An in-depth analysis of original antigenic sin in dengue virus infection.
Midgley CM; Bajwa-Joseph M; Vasanawathana S; Limpitikul W; Wills B; Flanagan A; Waiyaiya E; Tran HB; Cowper AE; Chotiyarnwong P; Grimes JM; Yoksan S; Malasit P; Simmons CP; Mongkolsapaya J; Screaton GR
J Virol; 2011 Jan; 85(1):410-21. PubMed ID: 20980526
[TBL] [Abstract][Full Text] [Related]
20. Role of NS1 antibodies in the pathogenesis of acute secondary dengue infection.
Jayathilaka D; Gomes L; Jeewandara C; Jayarathna GSB; Herath D; Perera PA; Fernando S; Wijewickrama A; Hardman CS; Ogg GS; Malavige GN
Nat Commun; 2018 Dec; 9(1):5242. PubMed ID: 30531923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
